Enantiomeric separation of bupropion by liquid chromatography on derivatized cyclofructan chiral stationary phase
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18470%2F22%3A50019392" target="_blank" >RIV/62690094:18470/22:50019392 - isvavai.cz</a>
Výsledek na webu
<a href="https://onlinelibrary.wiley.com/doi/10.1002/chir.23496" target="_blank" >https://onlinelibrary.wiley.com/doi/10.1002/chir.23496</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/chir.23496" target="_blank" >10.1002/chir.23496</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Enantiomeric separation of bupropion by liquid chromatography on derivatized cyclofructan chiral stationary phase
Popis výsledku v původním jazyce
High-performance liquid chromatography (HPLC) is an ideal tool for enantiomeric separations of different drugs. In this study, the direct enantioseparation of bupropion, an atypical antidepressant structurally related to cathinone, was explored by using five chiral columns, including three based on derivatized cyclofructans, macrocyclic glycopeptide teicoplanin, and an immobilized amylose derivative under multimodal elution conditions. Baseline enantioseparation was obtained on the LarihcShell CF6-RN column, with derivatized cyclofructan 6, in the polar organic mode. The effects of the mobile-phase composition, type and content of major components, the nature and the amount of mobile-phase additives, and the column temperature on the retention, selectivity, and resolution were investigated to optimize enantioseparation. The calibration curve was linear in the range of 10-125 mu g/ml for each enantiomer. The limits of detection and quantification were 0.1 and 0.3 mu g/ml for both enantiomers of bupropion. The chiral recognition was controlled especially by H bonds, pi-pi, dipole-dipole interactions, and steric effects. Finally, the developed method was applied to the determination of bupropion in the commercially available drug.
Název v anglickém jazyce
Enantiomeric separation of bupropion by liquid chromatography on derivatized cyclofructan chiral stationary phase
Popis výsledku anglicky
High-performance liquid chromatography (HPLC) is an ideal tool for enantiomeric separations of different drugs. In this study, the direct enantioseparation of bupropion, an atypical antidepressant structurally related to cathinone, was explored by using five chiral columns, including three based on derivatized cyclofructans, macrocyclic glycopeptide teicoplanin, and an immobilized amylose derivative under multimodal elution conditions. Baseline enantioseparation was obtained on the LarihcShell CF6-RN column, with derivatized cyclofructan 6, in the polar organic mode. The effects of the mobile-phase composition, type and content of major components, the nature and the amount of mobile-phase additives, and the column temperature on the retention, selectivity, and resolution were investigated to optimize enantioseparation. The calibration curve was linear in the range of 10-125 mu g/ml for each enantiomer. The limits of detection and quantification were 0.1 and 0.3 mu g/ml for both enantiomers of bupropion. The chiral recognition was controlled especially by H bonds, pi-pi, dipole-dipole interactions, and steric effects. Finally, the developed method was applied to the determination of bupropion in the commercially available drug.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10406 - Analytical chemistry
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2022
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
CHIRALITY
ISSN
0899-0042
e-ISSN
1520-636X
Svazek periodika
34
Číslo periodika v rámci svazku
10
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
9
Strana od-do
1311-1319
Kód UT WoS článku
000828904600001
EID výsledku v databázi Scopus
2-s2.0-85134515767